Literature DB >> 21160704

Impaired diastolic function in naïve untreated human immunodeficiency virus infected patients.

Ugo Oliviero1, Giovanni Bonadies, Giorgio Bosso, Maria Foggia, Valentina Apuzzi, Mariarosaria Cotugno, Antonio Valvano, Enrico Leonardi, Guglielmo Borgia, Giuseppe Castello, Raffaele Napoli, Luigi Saccà.   

Abstract

AIM: To evaluate cardiac function and structure in untreated human immunodeficiency virus (HIV) patients without clinical evidence of cardiovascular disease.
METHODS: Fifty-three naïve untreated HIV-infected patients and 56 healthy control subjects underwent clinical assessment, electrocardiography (ECG) and echocardiography, including tissue doppler imaging. Moreover, a set of laboratory parameters was obtained from all subjects, including HIV-RNA plasma levels, CD4 cell counts and tumor necrosis factor-α levels.
RESULTS: The two groups showed normal ECG traces and no differences regarding systolic morphologic parameters. In contrast, a higher prevalence of left ventricular diastolic dysfunction (abnormal relaxation or pseudonormal filling pattern) was found in the HIV patients (36% vs 9% in patients and controls, respectively, P <0.001).
CONCLUSION: Subclinical cardiac abnormalities appear in an early stage of the HIV infection, independent of antiretroviral therapy. The data suggest that HIV per se plays a role in the genesis of diastolic dysfunction.

Entities:  

Keywords:  Cardiovascular risk factors; Diastolic function; Human immunodeficiency virus; Naïve subjects

Year:  2010        PMID: 21160704      PMCID: PMC2999046          DOI: 10.4330/wjc.v2.i4.98

Source DB:  PubMed          Journal:  World J Cardiol


  19 in total

Review 1.  The treatment of heart failure with preserved ejection fraction ("diastolic heart failure").

Authors:  Karen Hogg; John McMurray
Journal:  Heart Fail Rev       Date:  2006-06       Impact factor: 4.214

2.  Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction.

Authors:  J H Stein; M A Klein; J L Bellehumeur; P E McBride; D A Wiebe; J D Otvos; J M Sosman
Journal:  Circulation       Date:  2001-07-17       Impact factor: 29.690

3.  Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.

Authors:  F J Palella; K M Delaney; A C Moorman; M O Loveless; J Fuhrer; G A Satten; D J Aschman; S D Holmberg
Journal:  N Engl J Med       Date:  1998-03-26       Impact factor: 91.245

4.  Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection.

Authors:  Samuel A Bozzette; Christopher F Ake; Henry K Tam; Sophia W Chang; Thomas A Louis
Journal:  N Engl J Med       Date:  2003-02-20       Impact factor: 91.245

Review 5.  Cardiovascular risk factors in HIV-infected patients.

Authors:  Andrew Carr
Journal:  J Acquir Immune Defic Syndr       Date:  2003-09       Impact factor: 3.731

6.  Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease.

Authors:  Virginia A Triant; Hang Lee; Colleen Hadigan; Steven K Grinspoon
Journal:  J Clin Endocrinol Metab       Date:  2007-04-24       Impact factor: 5.958

7.  Long-term cardiovascular effects of levothyroxine therapy in young adults with congenital hypothyroidism.

Authors:  Mariacarolina Salerno; Ugo Oliviero; Teresa Lettiero; Vincenzo Guardasole; Dario Maria Mattiacci; Lavinia Saldamarco; Donatella Capalbo; Antonio Lucariello; Luigi Saccà; Antonio Cittadini
Journal:  J Clin Endocrinol Metab       Date:  2008-04-29       Impact factor: 5.958

8.  Class of antiretroviral drugs and the risk of myocardial infarction.

Authors:  Nina Friis-Møller; Peter Reiss; Caroline A Sabin; Rainer Weber; Antonella d'Arminio Monforte; Wafaa El-Sadr; Rodolphe Thiébaut; Stephane De Wit; Ole Kirk; Eric Fontas; Matthew G Law; Andrew Phillips; Jens D Lundgren
Journal:  N Engl J Med       Date:  2007-04-26       Impact factor: 91.245

9.  Diffuse-regressive alterations and apoptosis of myocytes: possible causes of myocardial dysfunction in HIV-related cardiomyopathy.

Authors:  Geanete Pozzan; Carla Pagliari; Felipe Francisco Tuon; Cleusa Fumika Takakura; Monica R Kauffman; Maria Irma Seixas Duarte
Journal:  Int J Cardiol       Date:  2008-01-28       Impact factor: 4.164

10.  Silent cardiac dysfunction and exercise intolerance in HIV+ men receiving combined antiretroviral therapies.

Authors:  Gilles J Thöni; Iris Schuster; Guillaume Walther; Stéphane Nottin; Agnès Vinet; Franck Boccara; Jean-Marc Mauboussin; Isabelle Rouanet; Stéphane Edérhy; Michel Dauzat; Patick Messner-Pellenc; Philippe Obert
Journal:  AIDS       Date:  2008-11-30       Impact factor: 4.177

View more
  5 in total

1.  Cardiac manifestations in HIV infected children.

Authors:  Pradeep Singh; Alok Hemal; Sheetal Agarwal; Dinesh Kumar
Journal:  Indian J Pediatr       Date:  2014-05-25       Impact factor: 1.967

2.  Reduced diastolic function and left ventricular mass in HIV-negative preadolescent children exposed to antiretroviral therapy in utero.

Authors:  W Todd Cade; Alan D Waggoner; Sara Hubert; Melissa J Krauss; Gautam K Singh; E Turner Overton
Journal:  AIDS       Date:  2012-10-23       Impact factor: 4.177

3.  Cardiac involvement in HIV-positive patients.

Authors:  Efrat Daglan; Dan Yamin; Bogdana Manu; Anca Streinu-Cercel
Journal:  Germs       Date:  2013-03-01

4.  Left ventricular diastolic dysfunction in HIV-uninfected infants exposed in utero to antiretroviral therapy.

Authors:  Steven E Lipshultz; Nao Sasaki; Bruce Thompson; Benjamin W Eidem; Irene Cheng; Steven D Colan; Sharon E O'Brien; Shahnawaz Amdani; William T Shearer; Endel John Orav; Tracie L Miller; James D Wilkinson
Journal:  AIDS       Date:  2020-03-15       Impact factor: 4.177

5.  Diastolic dysfunction in people with HIV without known cardiovascular risk factors in Western Kenya.

Authors:  Bethel Woldu; Tecla M Temu; Nicholas Kirui; Bridgette Christopher; Samson Ndege; Wendy S Post; Jemima Kamano; Gerald S Bloomfield
Journal:  Open Heart       Date:  2022-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.